Why Trial Results Should Not Be Compared Too Casually Patients often see headlines comparing weight-loss percentages across different medications
For matters that extend beyond obtaining a lifestyle treatment safely and easily, we encourage you to consult your primary health practitioner in person whether for checkups, personal health concerns, or to inform them about your current treatments or treatment plans
GLP-1 medications like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda, Victoza) are becoming increasingly common in the U.S., with about 12% of adults having tried them, according to a KFF Health Tracking Poll
Luo Y, Liao C, Chen L, Zhang Y, Bao S, Deng A, Ke T, Li Q, Yang J